ENTRADA THERAPEUTICS, INC. (TRDA) Total liabilities 2023–2025
ENTRADA THERAPEUTICS, INC. (TRDA) total liabilities at each fiscal year-end, per SEC filings.
$71.2MFY2025 · since FY2023: $226.8M → $71.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $71.2M | -27.0% |
| FY2024 | $97.6M | -57.0% |
| FY2023 | $226.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TRDA financial trends
TRDA RevenueTRDA Net incomeTRDA Net marginTRDA Gross profitTRDA Gross marginTRDA Operating incomeTRDA Operating marginTRDA Operating cash flowTRDA Free cash flowTRDA Capital expendituresTRDA Return on equityTRDA Stock buybacksTRDA Dividends paidTRDA Total assetsTRDA Shareholders’ equityTRDA overview →